SCHEDULE 13D

Company

ACADIA PHARMACEUTICALS INC

Filed

May 2, 2005

Accession Number

0000947871-05-000915

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →